Share Price and Basic Stock Data
Last Updated: January 16, 2026, 4:23 am
| PEG Ratio | 4.20 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cenlub Industries Ltd operates in the engineering sector, focusing on manufacturing and supplying lubrication systems. As of the latest reporting period, the company’s stock price stood at ₹208, with a market capitalization of ₹97.0 Cr. Revenue trends have shown significant growth over the years, with sales reported at ₹53.93 Cr for FY 2023, up from ₹52.42 Cr in FY 2022. The company anticipates reaching ₹71.52 Cr in FY 2024 and ₹73.37 Cr in FY 2025, indicating a robust growth trajectory. Quarterly sales data reveals a notable increase, with Q2 FY 2024 sales reported at ₹20.14 Cr, a substantial rise from ₹19.36 Cr in Q1 FY 2024. The increase in sales can be attributed to enhanced operational efficiencies and demand recovery post-pandemic. Overall, Cenlub’s ability to scale its operations reflects positively on its market positioning within the engineering sector.
Profitability and Efficiency Metrics
Cenlub Industries has demonstrated commendable profitability metrics, with a reported net profit of ₹6.67 Cr for FY 2023, yielding a net profit margin of approximately 12.37% for the trailing twelve months (TTM). The company’s return on equity (ROE) stood at 14.7%, and return on capital employed (ROCE) was reported at 20.5%, indicating effective use of shareholder funds and capital. Operating profit margin (OPM) reported at 12.03% reflects a stable operational efficiency. The company recorded an interest coverage ratio of 2.97x, showcasing its ability to meet interest obligations comfortably. However, the cash conversion cycle (CCC) of 105 days indicates potential inefficiencies in working capital management, particularly when compared to the typical sector range of 60-90 days. This aspect represents both a challenge and an area for operational improvement.
Balance Sheet Strength and Financial Ratios
The financial health of Cenlub Industries is underscored by its solid balance sheet, with total assets reported at ₹90.28 Cr and total liabilities at ₹92.01 Cr as of FY 2025. The company’s borrowings stood at ₹4.27 Cr, reflecting a low debt level, which is favorable given the total equity of ₹63.46 Cr. The debt-to-equity ratio remains low, enhancing the company’s financial stability. Reserves have grown to ₹63.46 Cr, showcasing retained earnings and capacity for future investments. The price-to-book value (P/BV) ratio is reported at 1.36x, indicating a reasonably valued stock compared to its book value. However, the company’s current ratio of 1.32x suggests that it maintains a healthy liquidity position, yet it remains slightly below the ideal benchmark of 1.5x typically sought by investors in the sector.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cenlub Industries reflects a stable ownership structure, with promoters holding 51.34% of the equity, indicating a strong management commitment to the company. The public holds 48.66%, with the total number of shareholders reaching 8,687, which shows increasing retail investor interest. The gradual increase in public shareholding from 48.53% in Dec 2022 to 48.66% in Sep 2025 suggests growing confidence among investors. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may limit larger-scale investment inflows. This could impact liquidity and stock performance in volatile market conditions. The stability in promoter shareholding also provides a cushion against potential market fluctuations, fostering investor confidence in the company’s long-term prospects.
Outlook, Risks, and Final Insight
The outlook for Cenlub Industries appears promising, with anticipated revenue growth driven by operational efficiencies and market demand. However, risks remain, including potential fluctuations in raw material costs and the impact of global supply chain disruptions. Additionally, the company’s CCC of 105 days presents a risk to liquidity, necessitating improvements in working capital management. The absence of institutional investors could limit stock liquidity during market corrections, posing a risk to smaller investors. Overall, Cenlub Industries is well-positioned for growth, but it must navigate these risks carefully to enhance shareholder value. The strategic focus on improving operational efficiencies and managing working capital will be crucial in achieving sustainable long-term performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 211 Cr. | 620 | 1,028/540 | 16.8 | 218 | 0.48 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 24.9 Cr. | 83.0 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 6.52 Cr. | 15.1 | 16.4/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 7.97 Cr. | 12.9 | 16.0/10.3 | 4.68 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 45.7 Cr. | 0.49 | 6.33/0.48 | 5.50 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,757.58 Cr | 463.39 | 36.87 | 119.01 | 0.30% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14.35 | 15.62 | 11.13 | 12.21 | 19.36 | 20.14 | 19.81 | 19.09 | 16.88 | 16.71 | 20.68 | 13.98 | 21.12 |
| Expenses | 12.00 | 10.98 | 11.13 | 10.04 | 15.54 | 16.79 | 16.95 | 15.97 | 14.16 | 14.42 | 17.18 | 12.25 | 18.58 |
| Operating Profit | 2.35 | 4.64 | 0.00 | 2.17 | 3.82 | 3.35 | 2.86 | 3.12 | 2.72 | 2.29 | 3.50 | 1.73 | 2.54 |
| OPM % | 16.38% | 29.71% | 0.00% | 17.77% | 19.73% | 16.63% | 14.44% | 16.34% | 16.11% | 13.70% | 16.92% | 12.37% | 12.03% |
| Other Income | 0.13 | 0.29 | 0.50 | 0.12 | 0.27 | 0.36 | 0.50 | 0.38 | 0.55 | 0.65 | 0.96 | 0.60 | 0.50 |
| Interest | 0.09 | 0.03 | 0.03 | 0.11 | 0.13 | 0.07 | 0.10 | 0.05 | 0.09 | 0.16 | 0.11 | 0.10 | 0.16 |
| Depreciation | 0.37 | 0.13 | 0.11 | 0.20 | 0.18 | 0.23 | 0.22 | 0.17 | 0.19 | 0.20 | 0.28 | 0.20 | 0.26 |
| Profit before tax | 2.02 | 4.77 | 0.36 | 1.98 | 3.78 | 3.41 | 3.04 | 3.28 | 2.99 | 2.58 | 4.07 | 2.03 | 2.62 |
| Tax % | 25.25% | 25.58% | 41.67% | 25.25% | 22.22% | 28.45% | 30.26% | 25.30% | 36.12% | 25.19% | 35.38% | 25.12% | 25.19% |
| Net Profit | 1.51 | 3.54 | 0.21 | 1.48 | 2.94 | 2.44 | 2.11 | 2.46 | 1.91 | 1.94 | 2.64 | 1.52 | 1.96 |
| EPS in Rs | 3.24 | 7.59 | 0.45 | 3.17 | 6.31 | 5.23 | 4.53 | 5.28 | 4.10 | 4.16 | 5.66 | 3.26 | 4.20 |
Last Updated: December 27, 2025, 3:03 pm
Below is a detailed analysis of the quarterly data for Cenlub Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 21.12 Cr.. The value appears strong and on an upward trend. It has increased from 13.98 Cr. (Jun 2025) to 21.12 Cr., marking an increase of 7.14 Cr..
- For Expenses, as of Sep 2025, the value is 18.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.25 Cr. (Jun 2025) to 18.58 Cr., marking an increase of 6.33 Cr..
- For Operating Profit, as of Sep 2025, the value is 2.54 Cr.. The value appears strong and on an upward trend. It has increased from 1.73 Cr. (Jun 2025) to 2.54 Cr., marking an increase of 0.81 Cr..
- For OPM %, as of Sep 2025, the value is 12.03%. The value appears to be declining and may need further review. It has decreased from 12.37% (Jun 2025) to 12.03%, marking a decrease of 0.34%.
- For Other Income, as of Sep 2025, the value is 0.50 Cr.. The value appears to be declining and may need further review. It has decreased from 0.60 Cr. (Jun 2025) to 0.50 Cr., marking a decrease of 0.10 Cr..
- For Interest, as of Sep 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.10 Cr. (Jun 2025) to 0.16 Cr., marking an increase of 0.06 Cr..
- For Depreciation, as of Sep 2025, the value is 0.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.20 Cr. (Jun 2025) to 0.26 Cr., marking an increase of 0.06 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.62 Cr.. The value appears strong and on an upward trend. It has increased from 2.03 Cr. (Jun 2025) to 2.62 Cr., marking an increase of 0.59 Cr..
- For Tax %, as of Sep 2025, the value is 25.19%. The value appears to be increasing, which may not be favorable. It has increased from 25.12% (Jun 2025) to 25.19%, marking an increase of 0.07%.
- For Net Profit, as of Sep 2025, the value is 1.96 Cr.. The value appears strong and on an upward trend. It has increased from 1.52 Cr. (Jun 2025) to 1.96 Cr., marking an increase of 0.44 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.20. The value appears strong and on an upward trend. It has increased from 3.26 (Jun 2025) to 4.20, marking an increase of 0.94.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:00 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.48 | 29.82 | 31.34 | 35.67 | 37.11 | 48.10 | 39.04 | 40.96 | 52.42 | 53.93 | 71.52 | 73.37 | 72.49 |
| Expenses | 23.31 | 26.16 | 28.08 | 30.67 | 31.38 | 40.13 | 35.11 | 34.54 | 43.64 | 45.11 | 59.32 | 61.74 | 62.43 |
| Operating Profit | 2.17 | 3.66 | 3.26 | 5.00 | 5.73 | 7.97 | 3.93 | 6.42 | 8.78 | 8.82 | 12.20 | 11.63 | 10.06 |
| OPM % | 8.52% | 12.27% | 10.40% | 14.02% | 15.44% | 16.57% | 10.07% | 15.67% | 16.75% | 16.35% | 17.06% | 15.85% | 13.88% |
| Other Income | 0.57 | 0.52 | 0.72 | 0.93 | 1.01 | 1.45 | 2.20 | 1.37 | 1.40 | 1.27 | 1.25 | 2.54 | 2.71 |
| Interest | 1.98 | 2.01 | 1.90 | 1.81 | 1.21 | 1.22 | 1.10 | 1.07 | 0.59 | 0.26 | 0.41 | 0.40 | 0.53 |
| Depreciation | 0.36 | 0.40 | 0.55 | 0.75 | 0.78 | 1.01 | 0.97 | 0.96 | 0.92 | 0.80 | 0.83 | 0.83 | 0.94 |
| Profit before tax | 0.40 | 1.77 | 1.53 | 3.37 | 4.75 | 7.19 | 4.06 | 5.76 | 8.67 | 9.03 | 12.21 | 12.94 | 11.30 |
| Tax % | 32.50% | 32.20% | 34.64% | 35.01% | 26.95% | 31.29% | 32.27% | 30.38% | 19.26% | 26.14% | 26.45% | 30.91% | |
| Net Profit | 0.28 | 1.19 | 1.00 | 2.19 | 3.48 | 4.94 | 2.76 | 4.01 | 7.00 | 6.67 | 8.97 | 8.94 | 8.06 |
| EPS in Rs | 0.68 | 2.89 | 2.43 | 5.32 | 7.46 | 10.59 | 5.92 | 8.60 | 15.01 | 14.30 | 19.24 | 19.17 | 17.28 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 23.58% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 325.00% | -15.97% | 119.00% | 58.90% | 41.95% | -44.13% | 45.29% | 74.56% | -4.71% | 34.48% | -0.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -340.97% | 134.97% | -60.10% | -16.95% | -86.08% | 89.42% | 29.27% | -79.28% | 39.20% | -34.82% |
Cenlub Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 13% |
| 3 Years: | 12% |
| TTM: | -13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 34% |
| 3 Years: | 8% |
| TTM: | -20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 54% |
| 3 Years: | 30% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: December 10, 2025, 4:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.12 | 4.12 | 4.12 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 |
| Reserves | 9.74 | 10.93 | 11.99 | 15.16 | 18.65 | 23.55 | 24.77 | 28.89 | 35.88 | 42.57 | 51.25 | 59.98 | 63.46 |
| Borrowings | 14.27 | 15.37 | 11.37 | 16.91 | 10.68 | 10.19 | 12.46 | 8.03 | 6.02 | 4.88 | 4.24 | 4.56 | 4.27 |
| Other Liabilities | 7.56 | 7.83 | 9.49 | 9.63 | 11.55 | 13.92 | 12.10 | 14.33 | 12.99 | 10.61 | 17.49 | 21.08 | 19.62 |
| Total Liabilities | 35.69 | 38.25 | 36.97 | 46.36 | 45.54 | 52.32 | 53.99 | 55.91 | 59.55 | 62.72 | 77.64 | 90.28 | 92.01 |
| Fixed Assets | 5.69 | 6.88 | 9.86 | 20.50 | 18.98 | 20.87 | 20.65 | 20.08 | 19.39 | 19.77 | 17.43 | 23.46 | 25.53 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.27 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Investments | 1.04 | 4.56 | 1.60 | 0.07 | 0.06 | 0.05 | 0.02 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 28.96 | 26.81 | 25.51 | 25.52 | 26.18 | 31.40 | 33.32 | 35.77 | 40.16 | 42.95 | 60.21 | 66.80 | 66.48 |
| Total Assets | 35.69 | 38.25 | 36.97 | 46.36 | 45.54 | 52.32 | 53.99 | 55.91 | 59.55 | 62.72 | 77.64 | 90.28 | 92.01 |
Below is a detailed analysis of the balance sheet data for Cenlub Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.66 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.66 Cr..
- For Reserves, as of Sep 2025, the value is 63.46 Cr.. The value appears strong and on an upward trend. It has increased from 59.98 Cr. (Mar 2025) to 63.46 Cr., marking an increase of 3.48 Cr..
- For Borrowings, as of Sep 2025, the value is 4.27 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 4.56 Cr. (Mar 2025) to 4.27 Cr., marking a decrease of 0.29 Cr..
- For Other Liabilities, as of Sep 2025, the value is 19.62 Cr.. The value appears to be improving (decreasing). It has decreased from 21.08 Cr. (Mar 2025) to 19.62 Cr., marking a decrease of 1.46 Cr..
- For Total Liabilities, as of Sep 2025, the value is 92.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.28 Cr. (Mar 2025) to 92.01 Cr., marking an increase of 1.73 Cr..
- For Fixed Assets, as of Sep 2025, the value is 25.53 Cr.. The value appears strong and on an upward trend. It has increased from 23.46 Cr. (Mar 2025) to 25.53 Cr., marking an increase of 2.07 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 66.48 Cr.. The value appears to be declining and may need further review. It has decreased from 66.80 Cr. (Mar 2025) to 66.48 Cr., marking a decrease of 0.32 Cr..
- For Total Assets, as of Sep 2025, the value is 92.01 Cr.. The value appears strong and on an upward trend. It has increased from 90.28 Cr. (Mar 2025) to 92.01 Cr., marking an increase of 1.73 Cr..
Notably, the Reserves (63.46 Cr.) exceed the Borrowings (4.27 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -12.10 | -11.71 | -8.11 | -11.91 | -4.95 | -2.22 | -8.53 | -1.61 | 2.76 | 3.94 | 7.96 | 7.07 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 104.86 | 81.89 | 95.85 | 107.85 | 104.75 | 97.97 | 117.15 | 152.74 | 118.16 | 84.26 | 48.69 | 81.29 |
| Inventory Days | 122.33 | 122.96 | 125.55 | 97.65 | 94.25 | 48.38 | 86.94 | 26.46 | 44.52 | 73.29 | 85.42 | 83.60 |
| Days Payable | 116.39 | 103.11 | 133.73 | 112.70 | 125.12 | 100.77 | 129.33 | 116.19 | 107.32 | 91.02 | 70.78 | 59.89 |
| Cash Conversion Cycle | 110.79 | 101.73 | 87.67 | 92.80 | 73.88 | 45.57 | 74.76 | 63.01 | 55.36 | 66.53 | 63.33 | 105.00 |
| Working Capital Days | -51.28 | -58.39 | -26.90 | -19.34 | -1.67 | -14.04 | -21.04 | 15.51 | 31.40 | 34.31 | -2.76 | 11.49 |
| ROCE % | 9.41% | 12.54% | 11.88% | 14.95% | 15.55% | 21.49% | 10.26% | 16.34% | 20.97% | 18.81% | 22.47% | 20.47% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.24 | 2.44 | 2.88 | 0.69 | 5.39 |
| Diluted EPS (Rs.) | 4.24 | 2.44 | 2.88 | 0.69 | 5.39 |
| Cash EPS (Rs.) | 5.99 | 3.77 | 3.86 | 1.67 | 6.26 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 43.29 | 39.05 | 36.45 | 33.58 | 32.89 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 43.29 | 39.05 | 36.45 | 33.58 | 32.89 |
| Revenue From Operations / Share (Rs.) | 86.25 | 76.07 | 72.37 | 61.86 | 80.68 |
| PBDIT / Share (Rs.) | 13.05 | 10.30 | 10.14 | 6.78 | 12.12 |
| PBIT / Share (Rs.) | 11.30 | 8.97 | 9.16 | 5.80 | 11.24 |
| PBT / Share (Rs.) | 6.90 | 3.73 | 4.27 | 0.99 | 7.83 |
| Net Profit / Share (Rs.) | 4.24 | 2.44 | 2.88 | 0.68 | 5.38 |
| NP After MI And SOA / Share (Rs.) | 4.24 | 2.44 | 2.88 | 0.68 | 5.38 |
| PBDIT Margin (%) | 15.13 | 13.54 | 14.01 | 10.96 | 15.01 |
| PBIT Margin (%) | 13.10 | 11.79 | 12.65 | 9.37 | 13.93 |
| PBT Margin (%) | 7.99 | 4.90 | 5.90 | 1.61 | 9.70 |
| Net Profit Margin (%) | 4.92 | 3.20 | 3.97 | 1.11 | 6.67 |
| NP After MI And SOA Margin (%) | 4.92 | 3.20 | 3.97 | 1.11 | 6.67 |
| Return on Networth / Equity (%) | 9.80 | 6.24 | 7.89 | 2.04 | 16.37 |
| Return on Capital Employeed (%) | 18.04 | 14.61 | 18.75 | 12.66 | 25.77 |
| Return On Assets (%) | 3.94 | 2.34 | 3.09 | 0.79 | 6.93 |
| Long Term Debt / Equity (X) | 0.38 | 0.49 | 0.26 | 0.29 | 0.26 |
| Total Debt / Equity (X) | 0.90 | 1.07 | 0.93 | 0.96 | 0.86 |
| Asset Turnover Ratio (%) | 0.79 | 0.83 | 0.80 | 0.75 | 1.13 |
| Current Ratio (X) | 1.32 | 1.29 | 1.00 | 1.22 | 1.26 |
| Quick Ratio (X) | 1.05 | 0.94 | 0.68 | 0.92 | 1.05 |
| Inventory Turnover Ratio (X) | 3.14 | 3.16 | 3.21 | 3.89 | 5.21 |
| Interest Coverage Ratio (X) | 2.97 | 1.97 | 2.07 | 1.41 | 3.55 |
| Interest Coverage Ratio (Post Tax) (X) | 1.96 | 1.47 | 1.59 | 1.14 | 2.58 |
| Enterprise Value (Cr.) | 32.07 | 17.74 | 19.77 | 13.95 | 17.73 |
| EV / Net Operating Revenue (X) | 0.90 | 0.56 | 0.66 | 0.54 | 0.53 |
| EV / EBITDA (X) | 5.96 | 4.18 | 4.73 | 4.99 | 3.55 |
| MarketCap / Net Operating Revenue (X) | 0.68 | 0.24 | 0.35 | 0.30 | 0.35 |
| Price / BV (X) | 1.36 | 0.48 | 0.70 | 0.56 | 0.86 |
| Price / Net Operating Revenue (X) | 0.68 | 0.24 | 0.35 | 0.30 | 0.35 |
| EarningsYield | 0.07 | 0.12 | 0.11 | 0.03 | 0.18 |
After reviewing the key financial ratios for Cenlub Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 17, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For Diluted EPS (Rs.), as of Mar 17, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For Cash EPS (Rs.), as of Mar 17, the value is 5.99. This value is within the healthy range. It has increased from 3.77 (Mar 16) to 5.99, marking an increase of 2.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 43.29. It has increased from 39.05 (Mar 16) to 43.29, marking an increase of 4.24.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 43.29. It has increased from 39.05 (Mar 16) to 43.29, marking an increase of 4.24.
- For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 86.25. It has increased from 76.07 (Mar 16) to 86.25, marking an increase of 10.18.
- For PBDIT / Share (Rs.), as of Mar 17, the value is 13.05. This value is within the healthy range. It has increased from 10.30 (Mar 16) to 13.05, marking an increase of 2.75.
- For PBIT / Share (Rs.), as of Mar 17, the value is 11.30. This value is within the healthy range. It has increased from 8.97 (Mar 16) to 11.30, marking an increase of 2.33.
- For PBT / Share (Rs.), as of Mar 17, the value is 6.90. This value is within the healthy range. It has increased from 3.73 (Mar 16) to 6.90, marking an increase of 3.17.
- For Net Profit / Share (Rs.), as of Mar 17, the value is 4.24. This value is within the healthy range. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 4.24. This value is within the healthy range. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For PBDIT Margin (%), as of Mar 17, the value is 15.13. This value is within the healthy range. It has increased from 13.54 (Mar 16) to 15.13, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 17, the value is 13.10. This value is within the healthy range. It has increased from 11.79 (Mar 16) to 13.10, marking an increase of 1.31.
- For PBT Margin (%), as of Mar 17, the value is 7.99. This value is below the healthy minimum of 10. It has increased from 4.90 (Mar 16) to 7.99, marking an increase of 3.09.
- For Net Profit Margin (%), as of Mar 17, the value is 4.92. This value is below the healthy minimum of 5. It has increased from 3.20 (Mar 16) to 4.92, marking an increase of 1.72.
- For NP After MI And SOA Margin (%), as of Mar 17, the value is 4.92. This value is below the healthy minimum of 8. It has increased from 3.20 (Mar 16) to 4.92, marking an increase of 1.72.
- For Return on Networth / Equity (%), as of Mar 17, the value is 9.80. This value is below the healthy minimum of 15. It has increased from 6.24 (Mar 16) to 9.80, marking an increase of 3.56.
- For Return on Capital Employeed (%), as of Mar 17, the value is 18.04. This value is within the healthy range. It has increased from 14.61 (Mar 16) to 18.04, marking an increase of 3.43.
- For Return On Assets (%), as of Mar 17, the value is 3.94. This value is below the healthy minimum of 5. It has increased from 2.34 (Mar 16) to 3.94, marking an increase of 1.60.
- For Long Term Debt / Equity (X), as of Mar 17, the value is 0.38. This value is within the healthy range. It has decreased from 0.49 (Mar 16) to 0.38, marking a decrease of 0.11.
- For Total Debt / Equity (X), as of Mar 17, the value is 0.90. This value is within the healthy range. It has decreased from 1.07 (Mar 16) to 0.90, marking a decrease of 0.17.
- For Asset Turnover Ratio (%), as of Mar 17, the value is 0.79. It has decreased from 0.83 (Mar 16) to 0.79, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 17, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.29 (Mar 16) to 1.32, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 17, the value is 1.05. This value is within the healthy range. It has increased from 0.94 (Mar 16) to 1.05, marking an increase of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 17, the value is 3.14. This value is below the healthy minimum of 4. It has decreased from 3.16 (Mar 16) to 3.14, marking a decrease of 0.02.
- For Interest Coverage Ratio (X), as of Mar 17, the value is 2.97. This value is below the healthy minimum of 3. It has increased from 1.97 (Mar 16) to 2.97, marking an increase of 1.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 1.96. This value is below the healthy minimum of 3. It has increased from 1.47 (Mar 16) to 1.96, marking an increase of 0.49.
- For Enterprise Value (Cr.), as of Mar 17, the value is 32.07. It has increased from 17.74 (Mar 16) to 32.07, marking an increase of 14.33.
- For EV / Net Operating Revenue (X), as of Mar 17, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 16) to 0.90, marking an increase of 0.34.
- For EV / EBITDA (X), as of Mar 17, the value is 5.96. This value is within the healthy range. It has increased from 4.18 (Mar 16) to 5.96, marking an increase of 1.78.
- For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 16) to 0.68, marking an increase of 0.44.
- For Price / BV (X), as of Mar 17, the value is 1.36. This value is within the healthy range. It has increased from 0.48 (Mar 16) to 1.36, marking an increase of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 17, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 16) to 0.68, marking an increase of 0.44.
- For EarningsYield, as of Mar 17, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 16) to 0.07, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cenlub Industries Ltd:
- Net Profit Margin: 4.92%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.04% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.8% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.96
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12 (Industry average Stock P/E: 36.87)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.9
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.92%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | Plot No. 233 & 234, Sector-58, Faridabad Haryana 121004 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Madhu Mittal | Chairman & Managing Director |
| Mr. Aman Mittal | Whole Time Director |
| Mr. Ansh Mittal | Whole Time Director |
| Mr. Dinesh Kaushal | Independent Director |
| Mr. Kamlesh Kumar Johari | Independent Director |
| Mr. Tarun Kumar Gupta | Independent Director |
FAQ
What is the intrinsic value of Cenlub Industries Ltd?
Cenlub Industries Ltd's intrinsic value (as of 16 January 2026) is ₹210.16 which is 1.04% higher the current market price of ₹208.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹97.0 Cr. market cap, FY2025-2026 high/low of ₹520/203, reserves of ₹63.46 Cr, and liabilities of ₹92.01 Cr.
What is the Market Cap of Cenlub Industries Ltd?
The Market Cap of Cenlub Industries Ltd is 97.0 Cr..
What is the current Stock Price of Cenlub Industries Ltd as on 16 January 2026?
The current stock price of Cenlub Industries Ltd as on 16 January 2026 is ₹208.
What is the High / Low of Cenlub Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cenlub Industries Ltd stocks is ₹520/203.
What is the Stock P/E of Cenlub Industries Ltd?
The Stock P/E of Cenlub Industries Ltd is 12.0.
What is the Book Value of Cenlub Industries Ltd?
The Book Value of Cenlub Industries Ltd is 146.
What is the Dividend Yield of Cenlub Industries Ltd?
The Dividend Yield of Cenlub Industries Ltd is 0.00 %.
What is the ROCE of Cenlub Industries Ltd?
The ROCE of Cenlub Industries Ltd is 20.5 %.
What is the ROE of Cenlub Industries Ltd?
The ROE of Cenlub Industries Ltd is 14.7 %.
What is the Face Value of Cenlub Industries Ltd?
The Face Value of Cenlub Industries Ltd is 10.0.